Clincosm LogoSign in Get a demo

Glioblastoma

Showing NaN - NaN of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • SonoCloud-9 (SC9)
  • +3 more
  • Chicago, Illinois
  • +7 more
Jun 5, 2023

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)

Not yet recruiting
  • High Grade Glioma
  • +8 more
  • Aurora, Colorado
  • +17 more
May 2, 2023

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

    Recruiting
    • Astrocytoma, Grade IV
    • +3 more
    • CYNK-001 systemic and Intra cavity administration
    • Duarte, California
    • +5 more
    Jan 20, 2023

    Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)

    Completed
    • Diffuse Intrinsic Pontine Glioma
    • +6 more
    • Washington, District of Columbia
    • +6 more
    Jan 12, 2023

    Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

    Active, not recruiting
    • Anaplastic Astrocytoma
    • +2 more
    • Radiation Therapy
    • +2 more
    • Birmingham, Alabama
    • +162 more
    Dec 30, 2022

    Glioblastoma Trial in Canada, China, United States (drug, other, radiation)

    Active, not recruiting
    • Glioblastoma
    • Enzastaurin Hydrochloride
    • +3 more
    • Birmingham, Alabama
    • +62 more
    Oct 11, 2022

    Astrocytoma, Glioblastoma, Glioblastoma, IDH-Wildtype Trial in Chicago (drug, other, radiation)

    Recruiting
    • Astrocytoma
    • +4 more
    • Mycophenolate Mofetil
    • +3 more
    • Chicago, Illinois
      Northwestern University
    Aug 22, 2022

    Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)

    Recruiting
    • Glioblastoma
    • Adult-type Diffuse Gliomas
    • Beverly Hills, California
    • +83 more
    Jul 25, 2022

    Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

    Active, not recruiting
    • Glioblastoma Multiforme
    • +6 more
    • Dendritic cell immunotherapy
    • Birmingham, Alabama
    • +85 more
    May 12, 2022

    Glioblastoma Trial in Worldwide (DSP-7888 Dosing Emulsion, Bevacizumab)

    Active, not recruiting
    • Glioblastoma
    • Birmingham, Alabama
    • +60 more
    Apr 4, 2022

    Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma

    Active, not recruiting
    • Glioblastoma
      • Birmingham, Alabama
      • +18 more
      Mar 7, 2022

      Glioblastoma Trial in United States (Ad-RTS-hIL-12, Veledimex, Cemiplimab-Rwlc)

      Completed
      • Glioblastoma
      • Ad-RTS-hIL-12
      • +2 more
      • Los Angeles, California
      • +6 more
      Nov 3, 2021

      Glioblastoma Trial in United States (Ad-RTS-hIL-12, veledimex, Nivolumab)

      Completed
      • Glioblastoma
      • Ad-RTS-hIL-12
      • +2 more
      • Chicago, Illinois
      • +3 more
      Oct 1, 2021

      Glioblastoma Trial in United States (Ad-RTS-hIL-12, veledimex)

      Completed
      • Glioblastoma
      • Los Angeles, California
      • +3 more
      Sep 21, 2021

      Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)

      Completed
      • Brain Cancer
      • +10 more
      • DNX-2401
      • pembrolizumab
      • Little Rock, Arkansas
      • +14 more
      Jul 13, 2021

      Glioblastoma, Malignant Glioma Trial in Canada, Switzerland, United States (drug, radiation, device)

      Completed
      • Glioblastoma
      • Malignant Glioma
      • La Jolla, California
      • +7 more
      Apr 13, 2021

      Glioblastoma, Astrocytoma, Pineoblastoma Trial in Chicago (Stem Cell Transplant)

      Completed
      • Glioblastoma
      • +4 more
      • Stem Cell Transplant
      • Chicago, Illinois
        Children's Memorial Hospital
      Aug 3, 2020

      Glioblastoma Trial in Chicago (biological, radiation, drug)

      Recruiting
      • Glioblastoma
      • IDO1 Inhibitor BMS-986205
      • +3 more
      • Chicago, Illinois
        Northwestern University
      Jun 30, 2020

      Glioblastoma Trial in Worldwide (Depatuxizumab mafodotin, Temozolomide, Lomustine)

      Completed
      Has Results
      • Glioblastoma
      • Depatuxizumab mafodotin
      • +2 more
      • Palo Alto, California
      • +101 more
      May 8, 2020

      Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in United States (Bevacizumab, Rindopepimut (CDX-110) with

      Completed
      • Glioblastoma
      • +6 more
      • Birmingham, Alabama
      • +44 more
      Feb 12, 2020

      Glioblastoma Trial in Worldwide (enzastaurin, lomustine)

      Completed
      • Glioblastoma
      • Phoenix, Arizona
      • +97 more
      Sep 10, 2019

      Anaplastic Astrocytoma, Brain Stem Glioma, Childhood Mixed Glioma Trial in United States (radiation, other, drug)

      Completed
      Has Results
      • Anaplastic Astrocytoma
      • +12 more
      • 3-Dimensional Conformal Radiation Therapy
      • +5 more
      • Los Angeles, California
      • +11 more
      Jul 17, 2019

      Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Canada, Israel, United States (radiation, biological, other,

      Completed
      Has Results
      • Glioblastoma
      • +2 more
      • 3-Dimensional Conformal Radiation Therapy
      • +6 more
      • Mobile, Alabama
      • +329 more
      Jul 22, 2019

      Glioblastoma Trial in Canada, Israel, United States (VB-111 + bevacizumab, Bevacizumab)

      Completed
      • Glioblastoma
      • Birmingham, Alabama
      • +56 more
      Oct 22, 2018